Coronil: When and how Patanjali's ayurvedic cure for COVID-19 should be taken?

Follow us on

In a historic statement made by Swami Ramdev led Patanjali on Tuesday, the herbal company announced a drug called 'Coronil' which claims to treat COVID-19 from the roots. The 'Made in India' medicine which comes in the pack of three is made from Ayurvedic elements such as Tulsi, Giloy, and Ashwagandha and claims '100 percent favourable results.' In IndiaTV's special health segment 'Corona Se Jung Swami Ramdev Ke Sang,' the yoga guru said that the drug was launched after all the clinical trials were completed. He said that the ayurvedic ingredients in Coronil improves the body's immune system and fight other coronavirus symptoms like fever, cough, cold. 

Coronil has also been termed as the 'first Ayurvedic-clinically controlled, research, evidence, and trial based medicine for COVID19.' Firstly, the clinical control study in various cities of India was performed in which 280 corona patients were observed who showed a '100 percent recovery rate.' Later in the clinical control trial, 69 percent of patients turned negative from positive in 3 days and in 7 days 100 percent of patients turned negative.

ALSO READ: How Patanjali's Coronil will cure coronavirus patients in 14 days?

What does the Coronil kit contain?

Swami Ramdev, on Wednesday, shared that the three medicines in the kit include--Coronil, Swasari Wati, and Anu oil. The Swasari Wati gives relief from colds, diabetes, and fever, etc. The Anu oil is injected into the nose, causing the coronavirus present in the respiratory tract to enter the stomach later which it gets killed due to the acids present there.

ALSO READ: Swami Ramdev shares how COVID-19 battle can be fought through Coronil and yogasanas

What is the dose of Coronil?

The Coronil kit mainly contains three drugs. Eat 3 tablets of Shwasari thrice a day. Take 2 tablets of Coronil tablets 3 times. Always take the tablet with warm water and half an hour after the meal. These are dosages for the age group of 15–80 years. For children of 6-14 years of age, the dose will turn into half.

While knowledge about how Covid-19 impacts different populations is still evolving, research so far has revealed that certain factors like age, diabetes, heart disease, high blood pressure, obesity, genetic factors and even blood type can influence the severity of the outcome. According to the US Centers for Disease Control and Prevention (CDC), older adults and people who have severe underlying medical conditions like heart or lung disease or diabetes appear to be at greater risk for developing more serious complications from Covid-19 illness.

In fact, in the US, 8 out of 10 deaths reported have been in adults 65 years old and older, according to the CDC. The American Heart Association also warned that those with conditions that affect the cardiovascular system, such as heart disease and hypertension, are at greater risk of worse outcome due to Covid-19 complications than those with no preexisting conditions, Live Science reported.

A study published in the journal Clinical Infectious Diseases said that obesity in Covid-19 patients younger than 60 years is a risk factor for hospital admission. Another study published as a preprint online in the journal The Lancet Infectious Diseases, also found that obesity, especially in men, significantly increases the risk of developing severe pneumonia in Covid-19 patients.

However, it is not clear why obesity can increase the risk of the severe outcomes, although it is generally believed that higher body mass index could be a risk factor for severe infection. A study even found that people with blood group ''A'' may be more prone to Covid-19 infection while those with blood type ''O'' have a lower risk of contracting the virus.

For the study, researchers led by Wang Xinghuan with the Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University looked at blood group patterns of more than 2,000 infected patients in Wuhan and Shenzhen. Scientists believe that certain genetic factors can also influence the risk of severe outcome.

As reported by Live Science, while certain combinations of human leukocyte antigen (HLA) genes that train immune cells to recognize germs may safeguard people against Covid-19, other combinations may make them more vulnerable, according to a study published in the Journal of Virology.

-With IANS inputs

For all latest news and updates, stay tuned to our Facebook page